These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7024762)

  • 1. [Experiences with a chemically modified monospecies-insulin].
    Sailer D; Kolb S
    Med Klin; 1981 Aug; 76(17):479-81. PubMed ID: 7024762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial with porcine des-Phe B1 insulin. A comparative study with unmodified insulin on therapeutical efficacy, biological activity and immunogenicity.
    Santeusanio F; Massi-Benedetti M; Clementi A; Calabrese G; Bueti A; Picchio E; Brunetti P
    Diabete Metab; 1981 Sep; 7(3):173-9. PubMed ID: 7033008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?].
    Sachse G; Federlin K
    Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment with Des-Phe-Insulin].
    Hirn S; Pietschmann H
    Wien Klin Wochenschr; 1982 Dec; 94(24):662-5. PubMed ID: 6820587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of diabetic patients with insulin resistance and allergy using des-phe-insulin (author's transl)].
    Valdenaire K; Klein W
    Dtsch Med Wochenschr; 1979 Nov; 104(46):1637-9. PubMed ID: 499001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixtard 30 HM Penfill insulin treatment in selected young insulin-dependent diabetes mellitus patients. Romanian Young Diabetics Study Team (RYDST).
    Rom J Intern Med; 1997; 35(1-4):99-113. PubMed ID: 9562659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Des-phe-insulin-containing intermediary insulin compared with usual commercial preparations (author's transl)].
    Sachse G; Mäser E; Schäfer D; Federlin K
    Dtsch Med Wochenschr; 1982 Mar; 107(9):332-5. PubMed ID: 7037351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source.
    Baldwa VS; Bhandari CM; Pangaria A; Goyal RK
    Ups J Med Sci; 1977; 82(1):39-41. PubMed ID: 20078273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient perceptions of insulin detemir as reported through patient telephone surveys.
    Kerney DL; Paradis D; Brunton S
    Curr Med Res Opin; 2007 Sep; 23(9):2043-9. PubMed ID: 17640448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognosis of insulin-dependent diabetes mellitus].
    Deckert T
    Z Gesamte Inn Med; 1981 Jan; 36(1):4-8. PubMed ID: 7013293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 18. The accuracy of drawing up insulin by insulin treated diabetics.
    Wright S; Morris JT; Hartog M
    Diabete Metab; 1982 Mar; 8(1):7-8. PubMed ID: 7047253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy.
    Golightly LK; Jones MA; Hamamura DH; Stolpman NM; McDermott MT
    Pharmacotherapy; 2006 Oct; 26(10):1421-32. PubMed ID: 16999652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes.
    Hagelberg A; Ivert T; Efendić S; Ohrvik J; Anderson RE
    Scand Cardiovasc J; 2008 Feb; 42(1):71-6. PubMed ID: 18273733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.